Clinical statistical analysis plan for the ACCURE trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicentre trial

Abstract Background The primary treatment of ulcerative colitis (UC) is medical therapy using a standard step-up approach. An appendectomy might modulate the clinical course of UC, decreasing the incidence of relapses and reducing need for medication. The objective of the ACCURE trial is to assess t...

Full description

Bibliographic Details
Main Authors: Eva Visser, Lianne Heuthorst, Shri Pathmakanthan, Willem A. Bemelman, Geert R. D’Haens, Kelly Handley, Apostolos Fakis, Thomas D. Pinkney, Christianne J. Buskens, Marcel G. W. Dijkgraaf
Format: Article
Language:English
Published: BMC 2024-03-01
Series:Trials
Subjects:
Online Access:https://doi.org/10.1186/s13063-024-08037-5
_version_ 1827300905293185024
author Eva Visser
Lianne Heuthorst
Shri Pathmakanthan
Willem A. Bemelman
Geert R. D’Haens
Kelly Handley
Apostolos Fakis
Thomas D. Pinkney
Christianne J. Buskens
Marcel G. W. Dijkgraaf
author_facet Eva Visser
Lianne Heuthorst
Shri Pathmakanthan
Willem A. Bemelman
Geert R. D’Haens
Kelly Handley
Apostolos Fakis
Thomas D. Pinkney
Christianne J. Buskens
Marcel G. W. Dijkgraaf
author_sort Eva Visser
collection DOAJ
description Abstract Background The primary treatment of ulcerative colitis (UC) is medical therapy using a standard step-up approach. An appendectomy might modulate the clinical course of UC, decreasing the incidence of relapses and reducing need for medication. The objective of the ACCURE trial is to assess the efficacy of laparoscopic appendectomy in addition to standard medical treatment in maintaining remission in UC patients. This article presents the statistical analysis plan to evaluate the outcomes of the ACCURE trial. Design and methods The ACCURE trial was designed as a multicentre, randomised controlled trial. UC patients with a new diagnosis or a disease relapse within the past 12 months, treated with 5-ASA, corticosteroids, or immunomodulators until complete clinical and endoscopic remission (defined as total Mayo score < 3 with endoscopic subscore of 0 or 1), were counselled for inclusion. Also, patients previously treated with biologicals who had a washout period of at least 3 months were considered for inclusion. Patients were randomised (1:1) to laparoscopic appendectomy plus maintenance treatment or a control group (maintenance therapy only). The primary outcome is the 1-year UC relapse rate (defined as a total Mayo-score ≥ 5 with endoscopic subscore of 2 or 3, or clinically as an exacerbation of symptoms and rectal bleeding or FCP > 150 or intensified medical therapy other than 5-ASA therapy). Secondary outcomes include number of relapses per patient, time to first relapse, disease activity, number of colectomies, medication usage, and health-related quality of life. Discussion The ACCURE trial will provide comprehensive evidence whether adding an appendectomy to maintenance treatment is superior to maintenance treatment only in maintaining remission in UC patients. Trial registration Dutch Trial Register (NTR) NTR2883 . Registered May 3, 2011. ISRCTN, ISRCTN60945764 . Registered August 12, 2019.
first_indexed 2024-04-24T16:12:58Z
format Article
id doaj.art-2602170777af489dba211b9c9a08e844
institution Directory Open Access Journal
issn 1745-6215
language English
last_indexed 2024-04-24T16:12:58Z
publishDate 2024-03-01
publisher BMC
record_format Article
series Trials
spelling doaj.art-2602170777af489dba211b9c9a08e8442024-03-31T11:34:17ZengBMCTrials1745-62152024-03-0125111110.1186/s13063-024-08037-5Clinical statistical analysis plan for the ACCURE trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicentre trialEva Visser0Lianne Heuthorst1Shri Pathmakanthan2Willem A. Bemelman3Geert R. D’Haens4Kelly Handley5Apostolos Fakis6Thomas D. Pinkney7Christianne J. Buskens8Marcel G. W. Dijkgraaf9Department of Surgery, Amsterdam University Medical CentreDepartment of Surgery, Amsterdam University Medical CentreDepartment of Gastroenterology, Queen Elizabeth University Hospital BirminghamDepartment of Surgery, Amsterdam University Medical CentreDepartment of Gastroenterology and Hepatology, Amsterdam University Medical CentreUniversity of Birmingham Clinical Trials UnitDerby Clinical Trials Support Unit, University Hospitals of Derby and Burton NHS Foundation TrustAcademic Department of Surgery, University of BirminghamDepartment of Surgery, Amsterdam University Medical CentreDepartment of Epidemiology and Data Science, University Medical CentreAbstract Background The primary treatment of ulcerative colitis (UC) is medical therapy using a standard step-up approach. An appendectomy might modulate the clinical course of UC, decreasing the incidence of relapses and reducing need for medication. The objective of the ACCURE trial is to assess the efficacy of laparoscopic appendectomy in addition to standard medical treatment in maintaining remission in UC patients. This article presents the statistical analysis plan to evaluate the outcomes of the ACCURE trial. Design and methods The ACCURE trial was designed as a multicentre, randomised controlled trial. UC patients with a new diagnosis or a disease relapse within the past 12 months, treated with 5-ASA, corticosteroids, or immunomodulators until complete clinical and endoscopic remission (defined as total Mayo score < 3 with endoscopic subscore of 0 or 1), were counselled for inclusion. Also, patients previously treated with biologicals who had a washout period of at least 3 months were considered for inclusion. Patients were randomised (1:1) to laparoscopic appendectomy plus maintenance treatment or a control group (maintenance therapy only). The primary outcome is the 1-year UC relapse rate (defined as a total Mayo-score ≥ 5 with endoscopic subscore of 2 or 3, or clinically as an exacerbation of symptoms and rectal bleeding or FCP > 150 or intensified medical therapy other than 5-ASA therapy). Secondary outcomes include number of relapses per patient, time to first relapse, disease activity, number of colectomies, medication usage, and health-related quality of life. Discussion The ACCURE trial will provide comprehensive evidence whether adding an appendectomy to maintenance treatment is superior to maintenance treatment only in maintaining remission in UC patients. Trial registration Dutch Trial Register (NTR) NTR2883 . Registered May 3, 2011. ISRCTN, ISRCTN60945764 . Registered August 12, 2019.https://doi.org/10.1186/s13063-024-08037-5Statistical analysis planInflammatory bowel diseaseUlcerative colitisAppendectomyDisease recurrence
spellingShingle Eva Visser
Lianne Heuthorst
Shri Pathmakanthan
Willem A. Bemelman
Geert R. D’Haens
Kelly Handley
Apostolos Fakis
Thomas D. Pinkney
Christianne J. Buskens
Marcel G. W. Dijkgraaf
Clinical statistical analysis plan for the ACCURE trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicentre trial
Trials
Statistical analysis plan
Inflammatory bowel disease
Ulcerative colitis
Appendectomy
Disease recurrence
title Clinical statistical analysis plan for the ACCURE trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicentre trial
title_full Clinical statistical analysis plan for the ACCURE trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicentre trial
title_fullStr Clinical statistical analysis plan for the ACCURE trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicentre trial
title_full_unstemmed Clinical statistical analysis plan for the ACCURE trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicentre trial
title_short Clinical statistical analysis plan for the ACCURE trial: the effect of appendectomy on the clinical course of ulcerative colitis, a randomised international multicentre trial
title_sort clinical statistical analysis plan for the accure trial the effect of appendectomy on the clinical course of ulcerative colitis a randomised international multicentre trial
topic Statistical analysis plan
Inflammatory bowel disease
Ulcerative colitis
Appendectomy
Disease recurrence
url https://doi.org/10.1186/s13063-024-08037-5
work_keys_str_mv AT evavisser clinicalstatisticalanalysisplanfortheaccuretrialtheeffectofappendectomyontheclinicalcourseofulcerativecolitisarandomisedinternationalmulticentretrial
AT lianneheuthorst clinicalstatisticalanalysisplanfortheaccuretrialtheeffectofappendectomyontheclinicalcourseofulcerativecolitisarandomisedinternationalmulticentretrial
AT shripathmakanthan clinicalstatisticalanalysisplanfortheaccuretrialtheeffectofappendectomyontheclinicalcourseofulcerativecolitisarandomisedinternationalmulticentretrial
AT willemabemelman clinicalstatisticalanalysisplanfortheaccuretrialtheeffectofappendectomyontheclinicalcourseofulcerativecolitisarandomisedinternationalmulticentretrial
AT geertrdhaens clinicalstatisticalanalysisplanfortheaccuretrialtheeffectofappendectomyontheclinicalcourseofulcerativecolitisarandomisedinternationalmulticentretrial
AT kellyhandley clinicalstatisticalanalysisplanfortheaccuretrialtheeffectofappendectomyontheclinicalcourseofulcerativecolitisarandomisedinternationalmulticentretrial
AT apostolosfakis clinicalstatisticalanalysisplanfortheaccuretrialtheeffectofappendectomyontheclinicalcourseofulcerativecolitisarandomisedinternationalmulticentretrial
AT thomasdpinkney clinicalstatisticalanalysisplanfortheaccuretrialtheeffectofappendectomyontheclinicalcourseofulcerativecolitisarandomisedinternationalmulticentretrial
AT christiannejbuskens clinicalstatisticalanalysisplanfortheaccuretrialtheeffectofappendectomyontheclinicalcourseofulcerativecolitisarandomisedinternationalmulticentretrial
AT marcelgwdijkgraaf clinicalstatisticalanalysisplanfortheaccuretrialtheeffectofappendectomyontheclinicalcourseofulcerativecolitisarandomisedinternationalmulticentretrial